Theriva Biologics, Inc. (TOVX)

USD 1.17

(-1.68%)

Revenue Summary of Theriva Biologics, Inc.

  • Theriva Biologics, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Theriva Biologics, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Theriva Biologics, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Theriva Biologics, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Theriva Biologics, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Theriva Biologics, Inc. reported a quarterly revenue of 758 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Theriva Biologics, Inc. (2023 - 1993)

Historical Annual Revenue of Theriva Biologics, Inc. (2023 - 1993)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 3.16 Million USD 2969.69%
2009 103.08 Thousand USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2002 10 Thousand USD -98.86%
2001 874.09 Thousand USD 72.55%
2000 506.57 Thousand USD 26.84%
1999 399.37 Thousand USD -0.16%
1998 400 Thousand USD -20.0%
1997 500 Thousand USD 0.0%
1996 500 Thousand USD 400.0%
1995 100 Thousand USD 0.0%
1994 100 Thousand USD 0.0%
1993 100 Thousand USD 0.0%

Peer Revenue Comparison of Theriva Biologics, Inc.

Name Revenue Revenue Difference
ADC Therapeutics SA 69.55 Million USD 100.0%
Alto Neuroscience, Inc. - USD NaN%
Annovis Bio, Inc. - USD NaN%
Biohaven Pharmaceutical Holding Company Ltd. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 251.45 Million USD 100.0%
Nuvation Bio Inc. - USD NaN%
Nuvation Bio Inc. - USD NaN%
Arcus Biosciences, Inc. 117 Million USD 100.0%
Zymeworks Inc. 76.01 Million USD 100.0%